Jeff Hummel

Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia

Jeff Hummel, Richard A. Wells, Ian D. Dubé et al. · Oncogene · 1999 · 60 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +9

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma

Jeff Hummel, Ekaterina Safroneeva, Karen Mossman · Molecular Therapy · 2005 · 59 citations · Full text

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome

Natalie Grinshtein, Michael S Ventresca, Renate Margl et al. · Cancer Gene Therapy · 2008 · 29 citations · Full text

Vaccination, Vaccine Development, Vaccine Research +10

Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies.

Jeff Hummel, Brian D. Lichty, Márcio R. C. Reis et al. · PubMed · 1996 · 27 citations

Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214.

Derek J. Jonker, Sébastien J. Hotte, Albiruni Ryan Abdul Razak et al. · Journal of Clinical Oncology · 2017 · 20 citations

Immunology, Immunoediting, Pathology +20